Search

everythinglearnresearchcommunity

for

Search:↓

Gestrinone pellets may help reduce pelvic pain in endometriosis safely.

Low-dose ethinyl estradiol and LNG-IUD are safer contraception options for obese women with PCOS.

The levonorgestrel intrauterine device for heavy periods may cause acne, hair loss, and excess hair growth.

Manage PCOS in primary care with weight loss, psychological support, medication, and monitoring for health risks.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Hormonal balance is vital for women's health and performance, but therapies like contraceptives and steroids have both benefits and risks.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

Hormonal contraceptives are effective for teens but require careful consideration of side effects and individual health.

Synthetic 19-norprogestins promote bone cell growth and function through their non-phenolic metabolites.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Oral contraceptives with CPA improve overall quality of life for women with PCOS.

Oral contraceptives with cyproterone acetate improved quality of life for women with PCOS more than those with levonorgestrel.

Both LNG-IUD and systemic progestins are effective for fertility-sparing treatment, but close monitoring is needed due to recurrence risk.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Women with PCOS are more likely to experience sexual dysfunction, but lifestyle changes and weight loss can improve sexual function.

The combination of azelaic acid, minoxidil, and caffeine significantly increased the survival of skin flaps by affecting certain body channels and nitric oxide levels.

Hormonal contraceptives may reduce social behavior and sexual motivation by lowering allopregnanolone levels.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Hurricane Sandy increased contamination in estuarine sediments in New Jersey and New York.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

Ethinylestradiol/Chlormadinone Acetate is a safe and effective birth control pill that also helps regulate menstrual cycles, reduces period pain, and treats certain skin and hair conditions.

MPZL3 is crucial for seborrheic dermatitis development.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.